Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 25 ... expenses by 25% (net of non-routine charges)$9.6 million settlement of patent infringement caseReduced net debt from $16.2 million at September 30 to $6.7 ... Puehringer added.Vice President and CFO John P. Jordan said, "Our decisive actions ahead of the curve last year reset our cost structure for reduced activity levels. ...
2009 NOV 23 ... Cerimon also announced that it recently received notification from the United States Patent and Trademark Office allowing patent claims covering its diclofenac patch. ... Trial Research, Cyclooxygenase Inhibitor, Diclofenac, NSAID, Pain Management, Patents Actions, Pharmaceuticals, Soft Tissue Injuries, Therapy, Treatment, Cerimon Pharmaceuticals Inc. ...
2009 NOV 23 ... manufacture, use or sale of the products described in Lupin's ANDA. U.S. Patent No. 6,340,475 will expire in 2016, U.S. Patent No. 6,488,962 will expire in 2020, U.S. ... Technology, Biotechnology, Drug Development, FDA, Hypoglycemic Agent, Metformin, Patents Actions, Regulatory Actions, Therapy, Treatment, U.S. Food and Drug Administration, Depomed Inc. ...
2009 NOV 23 ... announced that it has reached a settlement with LecTec Corporation on outstanding patent litigation related to LecTec's U.S. Patent Nos. 5,536,263 and 5,741,510. ... of Endo Pharmaceuticals. Keywords: Endo Pharmaceuticals Inc., Patents Actions, Pharmaceutical Business, Pharmaceutical Company, Therapy, Treatment. This ...
2009 NOV 24 ... (HAIs). The new infection control (I.C.) line of lifts incorporate an industry-first, patent-pending lifting strap that can be completely disinfected with virtually any hard surface ... Diseases, Medical Devices, Technology, H1N1 Virus, Infectious Disease, Patents Actions, Swine Flu, Swine Influenza. This article was prepared by Health Risk ...
2009 NOV 24 ... of New Jersey named Glenbrook founder and president Gil Zweig a 2009 Thomas Alva Edison Patent Award Winner in November. In August, the New Jersey Inventors Hall of Fame honored ... or visit www.glenbrooktech.com. Keywords: Life Sciences, Patents Actions, Diagnosis, Diagnostics. This article was prepared by Life Science Weekly ...
2009 NOV 25 ... the agreement, the parties will end all outstanding litigation including antitrust and patent cross license disputes. AMD will withdraw all of its regulatory complaints against Intel ... product introductions and the demand for and market acceptance of Intel's products; actions taken by Intel's competitors, including product offerings and introductions, marketing ...
2009 NOV 23 ... Despite the price differences, there is little perceivable demand for off-patent drugs outside of the public healthcare sector. However, the prescribing habits of ... Pharmaceutical, Economics, Economies, Food, Pharmaceuticals, Public Health, Regulatory Actions, Therapy, Treatment, Research and Markets. This article was prepared by ...
2009 NOV 23 ... announced that it has reached a settlement with Endo Pharmaceuticals Inc. on outstanding patent litigation related to LecTec's U.S. Patent Nos. 5,536,263 and 5,741,510. Endo ... Endo Pharmaceuticals Inc., Marketing and Licensing Agreements, Pain Medicine, Patents Actions, Pharmaceutical Business, Pharmaceutical Company, Therapy, Treatment, LecTec ...
2009 NOV 24 ... ModiFace, the Toronto virtual makeover company that has developed patent-pending systems for simulating the effects of virtual hairstyles, anti-aging treatments, ... for further information. Keywords: ModiFace, Inc., Patents Actions, Weight Loss, Aging This article was prepared by Life Science Weekly ...
2009 NOV 26 ... evidence on the basicness of academic patents using German professor patents linked to patent opposition data from the European Patent Office (EPO).""Patent oppositions ... City:Louvain, Country:Belgium, City:Louvain, Country:Belgium, Life Sciences, Patents Actions, Social Science, University of Leuven.This article was prepared by Politics ...
2009 NOV 23 ... Ryogen LLC, a genomic start-up company, has been awarded a new patent titled "Isolated Genomic Polynucleotide Fragments from Chromosome 7". U.S. patent No. ... Diabetes, Diagnostics, Genetics, Inflammation, Metabolic Bone Disease, Obesity, Patents Actions, Protein Encoding, Proteomics, Ryogen LLC. This article was prepared by ...
2009 NOV 23 ... we secured the exclusive right in the United States to Cipla's amorphous rifaximin PCT Patent Application. The acquisition of the rights to Lupin's and Cipla's respective ... Disorder, Gastroparesis, Metoclopramide Hydrochloride, Pharmaceuticals, Regulatory Actions, Rifaximin, Therapy, Treatment, U.S. Food and Drug Administration, Xifaxan, Salix ...
2009 NOV 23 ... its existing complaint against Momenta Pharmaceuticals, Inc./Sandoz Inc. to include patent infringement of three additional patents related to the characterization of ... Services, Legal, Drugs, Glatiramer Acetate, Momenta Pharmaceuticals, Patents Actions, Pharmaceutical Business, Pharmaceutical Company, Teva Pharmaceutical Industries Ltd., ...
2009 NOV 23 ... liability for sales of generic products prior to a final resolution of outstanding patent litigation, including that relating to the generic versions of Neurontin®, ... Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Regulatory Actions, Tap Pharmaceutical Products Inc., Teva Pharmaceutical Industries Ltd., Therapy, ...
2009 NOV 23 ... as rudimentary. There is virtually no public drug reimbursement or IP protection; patent law was officially tightened in December 2000, although the effectiveness of this has ... Malaria, Mycobacteria, Mycobacterium Tuberculosis, Oncology, Pharmaceuticals, Regulatory Actions, Therapy, Treatment, U.S. Food and Drug Administration, Research and Markets. ...
2009 NOV 23 ... "With regard to other key Intermezzo=AE milestones, we announced that the United States Patent and Trademark Office issued a Notice of Allowance for one of our patent applications ... FDA, Hypnotics and Sedatives, Marketing and Licensing Agreements, Neuroscience, Patents Actions, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Purdue Pharma LP, ...
2009 NOV 23 ... Vermillion, Inc. , a molecular diagnostics company, announced that the U.S. Patent Office (USPTO) has issued patent number 7,605,003 titled "Use of biomarkers for ... Keywords: Diagnostics, Gynecology, Oncology, Ovarian Cancer, Ovarian Carcinoma, Patents Actions, Women's Health, Vermillion Inc. This article was prepared by Clinical ...
